Usefulness of fluoxetine in obese non-insulin-dependent diabetics: A multicenter study

Obesity Research

Volumn 4, Issue 4, 1996, Pages 391-396

  Daubresse, Jean Claude ^a  

^a Centre Hospitalier Universitaire de Charleroi   (Belgium)

Author keywords

Fasting insulin and c peptide levels; Metabolic control; Triglycerides; Weight reduction

Indexed keywords

FLUOXETINE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LIPID; PLACEBO; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FLUOXETINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; LIPIDS; MIDDLE AGED; OBESITY; PLACEBOS; TRIGLYCERIDES; WEIGHT LOSS;

EID: 0030185972     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1550-8528.1996.tb00247.x     Document Type: Article

References (5)

1. Andersen T, Backer OB, Stokholm KH, Quaade E. Randomized trial of diet and gastroplasty compared with diet alone in morbid obesity. N Engl J Med. 1984;310:352-356.
2. Bailey CJ. Metformin revisited : Its actions and indications for use. Diabet Med. 1988;5:315-320.
3. Clissold SP, Edwards C. Acarbose: A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs. 1988;35:214-243.
4. Ferguson JM, Feighner JP. Fluoxetine-induced weight loss in non-depressed overweight humans. Int J Obes. 1987;11:(suppl. 3): 163.
5. Fitzgerald FT. The problem of obesity. Annu Rev Med. 1981;32:221-231.